
591.21 BATS BZX Real-Time Price As of 2:02pm ET | ![]() Today’s Change | 538.01 Today|||52-Week Range 747.42 | -6.38% Year-to-Date |
Regeneron (REGN) Dips More Than Broader Markets: What You Should Know Jun 30 / Zacks.com - Paid Partner Content | Regeneron (REGN) Gains But Lags Market: What You Should Know Jun 24 / Zacks.com - Paid Partner Content |
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted Jun 30 / Zacks.com - Paid Partner Content | Regeneron (REGN) Dips More Than Broader Markets: What You Should Know Jun 22 / Zacks.com - Paid Partner Content |
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? Jun 29 / Zacks.com - Paid Partner Content | Regeneron (REGN) Moves 4.4% Higher: Will This Strength Last? Jun 20 / Zacks.com - Paid Partner Content |
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA Jun 25 / MotleyFool.com - Paid Partner Content |
Previous close | 590.95 |
Today’s open | 588.86 |
Day’s range | 586.21 - 595.21 |
Volume | 9,492 |
Average volume (3 months) | 689,903 |
Market cap | $67.3B |
Earnings growth (last year) | +133.99% |
Earnings growth (this year) | -41.76% |
Earnings growth (next 5 years) | +1.50% |
Revenue growth (last year) | +89.14% |
P/E ratio | 8.4 |
Price/Sales | 4.41 |
Price/Book | 3.55 |
Next reporting date | August 4, 2022 |
EPS forecast (this quarter) | $10.06 |
Annual revenue (last year) | $16.1B |
Annual profit (last year) | $8.1B |
Net profit margin | 50.25% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tarrytown, New York |